HK Stock MarketDetailed Quotes

01037 MAXNERVA TECH

Watchlist
  • 0.270
  • 0.0000.00%
Not Open Apr 25 04:51 CST
189.42MMarket Cap-10384P/E (TTM)

MAXNERVA TECH Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
-18.57%677.88M
-1.44%353.82M
39.59%832.46M
38.86%359M
13.93%596.35M
0.26%258.54M
21.44%523.42M
68.62%257.86M
32.13%431M
45.45%152.92M
Operating income
-18.57%677.88M
-1.44%353.82M
39.59%832.46M
38.86%359M
13.93%596.35M
0.26%258.54M
21.44%523.42M
68.62%257.86M
32.13%431M
45.45%152.92M
Cost of sales
17.61%-581.1M
0.65%-302.71M
-46.26%-705.31M
-47.05%-304.69M
-12.37%-482.23M
5.33%-207.2M
-21.30%-429.15M
-75.11%-218.87M
-76.58%-353.79M
-38.59%-124.99M
Operating expenses
17.61%-581.1M
0.65%-302.71M
-46.26%-705.31M
-47.05%-304.69M
-12.37%-482.23M
5.33%-207.2M
-21.30%-429.15M
-75.11%-218.87M
-76.58%-353.79M
-38.59%-124.99M
Gross profit
-23.88%96.78M
-5.91%51.1M
11.42%127.15M
5.78%54.31M
21.06%114.12M
31.68%51.35M
22.10%94.26M
39.59%39M
-38.64%77.21M
86.81%27.94M
Selling expenses
-0.54%-37.16M
1.58%-16.53M
-43.89%-36.96M
-187.62%-16.79M
-124.20%-25.69M
-87.42%-5.84M
-1.60%-11.46M
47.71%-3.12M
19.99%-11.28M
21.02%-5.96M
Administrative expenses
-0.14%-53.84M
-6.94%-23.51M
-14.16%-53.76M
0.27%-21.98M
3.57%-47.09M
8.59%-22.04M
3.25%-48.83M
-32.08%-24.11M
4.21%-50.47M
9.24%-18.26M
Research and development expenses
11.09%-9.02M
50.79%-3.24M
40.29%-10.14M
22.38%-6.57M
-55.07%-16.99M
-177.67%-8.47M
-140.36%-10.95M
-27.88%-3.05M
---4.56M
---2.39M
Revaluation surplus
-52.21%964K
----
-89.07%2.02M
----
467.97%18.46M
----
---5.02M
----
----
----
-Changes in the fair value of financial assets
-52.21%964K
----
-89.07%2.02M
----
467.97%18.46M
----
---5.02M
----
----
----
Impairment and provision
-172.24%-9.11M
----
-13.42%-3.35M
----
15.49%-2.95M
----
-144.37%-3.49M
----
97.50%-1.43M
----
-Impairment of intangible assets
---10.63M
----
----
----
----
----
----
----
----
----
-Other impairment is provision
145.47%1.52M
----
-13.42%-3.35M
----
15.49%-2.95M
----
-144.37%-3.49M
----
97.50%-1.43M
----
Special items of operating profit
-69.05%2.3M
269.40%3.08M
300.22%7.44M
-58.00%-1.82M
-158.52%-3.72M
-168.70%-1.15M
46.82%6.35M
-68.48%1.67M
-51.60%4.33M
160.09%5.31M
Operating profit
-128.03%-9.08M
52.63%10.91M
-10.37%32.4M
-48.37%7.15M
73.24%36.14M
33.27%13.85M
51.22%20.86M
56.29%10.39M
27.83%13.8M
131.74%6.65M
Financing income
16.52%1.64M
-21.08%644K
-4.03%1.4M
-25.41%816K
-3.50%1.46M
-19.26%1.09M
9.54%1.52M
14.54%1.36M
-50.66%1.38M
8.83%1.18M
Share of profits of associates
-42.60%-4.73M
-205.07%-2.35M
---3.32M
---769K
----
----
----
----
----
---274K
Share of profit from joint venture company
----
----
----
----
----
----
98.87%-4K
----
---353K
----
Special items of earning before tax
---2.02M
----
----
----
----
----
----
----
----
----
Earning before tax
-146.57%-14.2M
27.98%9.21M
-18.94%30.48M
-51.84%7.2M
68.07%37.61M
27.21%14.94M
50.90%22.38M
55.42%11.75M
9.05%14.83M
138.06%7.56M
Tax
0.64%-2.64M
-311.59%-3.52M
20.71%-2.65M
75.30%-854K
56.78%-3.35M
-69.96%-3.46M
-138.00%-7.74M
-33.12%-2.03M
73.24%-3.25M
-758.43%-1.53M
After-tax profit from continuing operations
-160.48%-16.83M
-10.20%5.7M
-18.77%27.83M
-44.78%6.34M
134.12%34.26M
18.25%11.49M
26.43%14.63M
61.08%9.71M
703.82%11.58M
130.09%6.03M
Earning after tax
-160.48%-16.83M
-10.20%5.7M
-18.77%27.83M
-44.78%6.34M
134.12%34.26M
18.25%11.49M
26.43%14.63M
61.08%9.71M
703.82%11.58M
130.09%6.03M
Profit attributable to shareholders
-160.48%-16.83M
-10.20%5.7M
-18.77%27.83M
-44.78%6.34M
134.12%34.26M
18.25%11.49M
26.43%14.63M
61.08%9.71M
703.82%11.58M
130.09%6.03M
Basic earnings per share
-160.45%-0.024
-10.00%0.0081
-19.96%0.0397
-46.75%0.009
122.42%0.0496
14.19%0.0169
25.99%0.0223
60.87%0.0148
704.55%0.0177
130.36%0.0092
Diluted earnings per share
-160.45%-0.024
-10.00%0.0081
-19.96%0.0397
-46.75%0.009
122.42%0.0496
14.19%0.0169
25.99%0.0223
60.87%0.0148
704.55%0.0177
130.36%0.0092
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover -18.57%677.88M-1.44%353.82M39.59%832.46M38.86%359M13.93%596.35M0.26%258.54M21.44%523.42M68.62%257.86M32.13%431M45.45%152.92M
Operating income -18.57%677.88M-1.44%353.82M39.59%832.46M38.86%359M13.93%596.35M0.26%258.54M21.44%523.42M68.62%257.86M32.13%431M45.45%152.92M
Cost of sales 17.61%-581.1M0.65%-302.71M-46.26%-705.31M-47.05%-304.69M-12.37%-482.23M5.33%-207.2M-21.30%-429.15M-75.11%-218.87M-76.58%-353.79M-38.59%-124.99M
Operating expenses 17.61%-581.1M0.65%-302.71M-46.26%-705.31M-47.05%-304.69M-12.37%-482.23M5.33%-207.2M-21.30%-429.15M-75.11%-218.87M-76.58%-353.79M-38.59%-124.99M
Gross profit -23.88%96.78M-5.91%51.1M11.42%127.15M5.78%54.31M21.06%114.12M31.68%51.35M22.10%94.26M39.59%39M-38.64%77.21M86.81%27.94M
Selling expenses -0.54%-37.16M1.58%-16.53M-43.89%-36.96M-187.62%-16.79M-124.20%-25.69M-87.42%-5.84M-1.60%-11.46M47.71%-3.12M19.99%-11.28M21.02%-5.96M
Administrative expenses -0.14%-53.84M-6.94%-23.51M-14.16%-53.76M0.27%-21.98M3.57%-47.09M8.59%-22.04M3.25%-48.83M-32.08%-24.11M4.21%-50.47M9.24%-18.26M
Research and development expenses 11.09%-9.02M50.79%-3.24M40.29%-10.14M22.38%-6.57M-55.07%-16.99M-177.67%-8.47M-140.36%-10.95M-27.88%-3.05M---4.56M---2.39M
Revaluation surplus -52.21%964K-----89.07%2.02M----467.97%18.46M-------5.02M------------
-Changes in the fair value of financial assets -52.21%964K-----89.07%2.02M----467.97%18.46M-------5.02M------------
Impairment and provision -172.24%-9.11M-----13.42%-3.35M----15.49%-2.95M-----144.37%-3.49M----97.50%-1.43M----
-Impairment of intangible assets ---10.63M------------------------------------
-Other impairment is provision 145.47%1.52M-----13.42%-3.35M----15.49%-2.95M-----144.37%-3.49M----97.50%-1.43M----
Special items of operating profit -69.05%2.3M269.40%3.08M300.22%7.44M-58.00%-1.82M-158.52%-3.72M-168.70%-1.15M46.82%6.35M-68.48%1.67M-51.60%4.33M160.09%5.31M
Operating profit -128.03%-9.08M52.63%10.91M-10.37%32.4M-48.37%7.15M73.24%36.14M33.27%13.85M51.22%20.86M56.29%10.39M27.83%13.8M131.74%6.65M
Financing income 16.52%1.64M-21.08%644K-4.03%1.4M-25.41%816K-3.50%1.46M-19.26%1.09M9.54%1.52M14.54%1.36M-50.66%1.38M8.83%1.18M
Share of profits of associates -42.60%-4.73M-205.07%-2.35M---3.32M---769K-----------------------274K
Share of profit from joint venture company ------------------------98.87%-4K-------353K----
Special items of earning before tax ---2.02M------------------------------------
Earning before tax -146.57%-14.2M27.98%9.21M-18.94%30.48M-51.84%7.2M68.07%37.61M27.21%14.94M50.90%22.38M55.42%11.75M9.05%14.83M138.06%7.56M
Tax 0.64%-2.64M-311.59%-3.52M20.71%-2.65M75.30%-854K56.78%-3.35M-69.96%-3.46M-138.00%-7.74M-33.12%-2.03M73.24%-3.25M-758.43%-1.53M
After-tax profit from continuing operations -160.48%-16.83M-10.20%5.7M-18.77%27.83M-44.78%6.34M134.12%34.26M18.25%11.49M26.43%14.63M61.08%9.71M703.82%11.58M130.09%6.03M
Earning after tax -160.48%-16.83M-10.20%5.7M-18.77%27.83M-44.78%6.34M134.12%34.26M18.25%11.49M26.43%14.63M61.08%9.71M703.82%11.58M130.09%6.03M
Profit attributable to shareholders -160.48%-16.83M-10.20%5.7M-18.77%27.83M-44.78%6.34M134.12%34.26M18.25%11.49M26.43%14.63M61.08%9.71M703.82%11.58M130.09%6.03M
Basic earnings per share -160.45%-0.024-10.00%0.0081-19.96%0.0397-46.75%0.009122.42%0.049614.19%0.016925.99%0.022360.87%0.0148704.55%0.0177130.36%0.0092
Diluted earnings per share -160.45%-0.024-10.00%0.0081-19.96%0.0397-46.75%0.009122.42%0.049614.19%0.016925.99%0.022360.87%0.0148704.55%0.0177130.36%0.0092
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg